Featured Research

from universities, journals, and other organizations

Arizona's smoking ban reduced hospital visits

Date:
May 23, 2010
Source:
University of Arizona
Summary:
Since the 2007 state law that bans smoking in public venues took effect, admissions for ailments related to secondhand smoke have declined by as much as 33 percent.

Two University of Arizona researchers have studied the relationship between Arizona's 2007 law that bans smoking in public places and hospitalization rates for a range of ailments related to secondhand smoke exposure.

Their results: Admissions for acute myocardial infarction or AMI, stroke, asthma and angina decreased following the implementation of the ban.

Reductions in hospital charges are estimated to total more than $16 million in the first 13 months after the ban.

Patricia M. Herman and Michele E. Walsh, both researchers in the UA psychology department, used public data on monthly hospital admissions in Arizona from January 2004 through May 2008 for their analyses.

To control for other reasons why hospital admissions change over time, they compared admissions for those primary diagnoses before and after May 1, 2007 -- the start date of the smoking ban -- to admissions for four diagnoses not associated with secondhand smoke: appendicitis, kidney stones, acute cholecystitis and ulcers.

They also compared admissions in Arizona counties with preexisting county or municipal smoking bans -- which would be expected to show little effect from the statewide ban -- to counties with no previous bans.

Their results showed statistically significant reductions in hospital admissions of 13 percent for AMI, 33 percent for unstable angina, 14 percent for acute stroke and 22 percent for asthma in counties with no previous bans over what was seen in counties with previous bans.

There were no statistically significant changes seen for diagnoses not associated with secondhand smoke.


Story Source:

The above story is based on materials provided by University of Arizona. Note: Materials may be edited for content and length.


Journal Reference:

  1. P. M. Herman, M. E. Walsh. Hospital Admissions for Acute Myocardial Infarction, Angina, Stroke, and Asthma After Implementation of Arizona's Comprehensive Statewide Smoking Ban. American Journal of Public Health, 2010; DOI: 10.2105/AJPH.2009.179572

Cite This Page:

University of Arizona. "Arizona's smoking ban reduced hospital visits." ScienceDaily. ScienceDaily, 23 May 2010. <www.sciencedaily.com/releases/2010/05/100520093034.htm>.
University of Arizona. (2010, May 23). Arizona's smoking ban reduced hospital visits. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2010/05/100520093034.htm
University of Arizona. "Arizona's smoking ban reduced hospital visits." ScienceDaily. www.sciencedaily.com/releases/2010/05/100520093034.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins